about
sameAs
Molecular cloning and expression of a functional snake venom vascular endothelium growth factor (VEGF) from the Bothrops insularis pit viper. A new member of the VEGF family of proteins.Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in miceImmunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC.Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil.Adhesin activity of Leptospira interrogans lipoprotein identified by in vivo and in vitro shotgun phage display.Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins.Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentiumControlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice.Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine productionIntranasal vaccines for protection against respiratory and systemic bacterial infections.Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants.Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges.Serotype-independent pneumococcal vaccines.Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli.Aerobic exercise attenuates pulmonary inflammation induced by Streptococcus pneumoniae.Expression of Streptococcus pneumoniae antigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) by Lactobacillus casei.Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.Impaired expression of CXCL5 and matrix metalloproteinases in the lungs of mice with high susceptibility to Streptococcus pneumoniae infection.Antibodies produced against a fragment of filamentous haemagglutinin (FHA) of Bordetella pertussis are able to inhibit hemagglutination induced by the whole adhesin.Immunization of mice with Lactobacillus casei expressing intimin fragments produces antibodies able to inhibit the adhesion of enteropathogenic Escherichia coli to cultivated epithelial cells.Systems analysis of subjects acutely infected with the Chikungunya virusHaemagglutination induced by Bordetella pertussis filamentous haemagglutinin adhesin (FHA) is inhibited by antibodies produced against FHA(430-873) fragment expressed in Lactobacillus caseiExpression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in miceNasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challengeDNA vaccines expressing pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant proteinProtection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A)Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in miceCharacterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniaeEvaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A
P50
Q30702674-C4490E21-59C2-474D-A2D6-C2E20D07F95EQ33594345-920B8402-40E6-4562-B9C4-B62F92A672B6Q33594345-CE9842BD-89F5-477F-BD5E-046C2F8230A9Q33725192-A34B37E5-3719-418A-BD29-875B8034534AQ33899358-74C34DED-4786-46D0-B2A6-8649CECDA0E0Q33899407-9348C1E6-C03D-4CC2-8CBD-36F05C038606Q34091515-76A997D6-2781-4311-AD98-EDA7B2A0B5E3Q34537180-72ECE69E-AB23-4D41-8230-9BE3E2152123Q35021099-68A3364F-B822-435C-BD5F-32A2DA688CE3Q35530236-BF295DC3-1610-4DBD-98E2-68ABB4497544Q36191618-C772A599-5C72-48A1-BE6A-7B52C30360B2Q36253907-55779334-E70D-4E1B-B4A1-BA1CBC286BA9Q36497698-6AC97525-BFF7-4DDE-8CB8-6133660093C6Q36837156-D245727F-E38C-4D30-95FA-20F2E554DBFBQ37876307-48B84F34-4ACC-40E0-823B-8C1ECCD33300Q37894916-7473E9C8-5777-4A75-96A9-0E76E25E5DEFQ38069943-3E24DED3-563A-4780-99E8-CF2FB4B2C282Q40710316-8CB4F1B0-F46B-45A3-BF4D-5363C897DEA9Q41752736-E8890495-39CC-4B74-AE67-8441DEC88753Q44624566-89114773-718A-4D7D-950A-F618759E3B37Q44700058-7D30F120-B9FC-42E8-A302-BBEC462EB3F1Q47717751-E1AF8F57-FEF9-4005-8259-3DE34B5E2723Q47907889-610F95E2-81C2-4DE4-A120-8276F37AE312Q50231847-5B525026-DA8F-4036-AAC9-F389E93AAA6EQ66679599-BD640D75-49B9-45E2-B018-F4979B9AEAECQ79361056-2E86EE54-54EA-47E0-BB7A-4EA34066A652Q80546347-86C09126-497C-422C-BEFB-D2356CB327CFQ81057301-094A11CD-337B-4436-8B58-A4D2500AAB8BQ82809417-5B940580-69AA-410A-A5D7-E701E22FB519Q83144010-7430CD62-2179-4930-B671-E88478473521Q83861773-F98F5A5A-3D08-44B8-AAC3-AB412E0503CFQ84976365-E9731B75-B307-44E7-AC52-C66652AE5FF3Q92689470-20030FB2-DB85-4D0B-BF4F-1C337BDEC389
P50
description
researcher ORCID ID = 0000-0003-4849-3062
@en
wetenschapper
@nl
name
Maria Leonor S. Oliveira
@an
Maria Leonor S. Oliveira
@ast
Maria Leonor S. Oliveira
@ca
Maria Leonor S. Oliveira
@da
Maria Leonor S. Oliveira
@de
Maria Leonor S. Oliveira
@en
Maria Leonor S. Oliveira
@es
Maria Leonor S. Oliveira
@eu
Maria Leonor S. Oliveira
@fr
Maria Leonor S. Oliveira
@gl
type
label
Maria Leonor S. Oliveira
@an
Maria Leonor S. Oliveira
@ast
Maria Leonor S. Oliveira
@ca
Maria Leonor S. Oliveira
@da
Maria Leonor S. Oliveira
@de
Maria Leonor S. Oliveira
@en
Maria Leonor S. Oliveira
@es
Maria Leonor S. Oliveira
@eu
Maria Leonor S. Oliveira
@fr
Maria Leonor S. Oliveira
@gl
altLabel
Maria Leonor S Oliveira
@en
prefLabel
Maria Leonor S. Oliveira
@an
Maria Leonor S. Oliveira
@ast
Maria Leonor S. Oliveira
@ca
Maria Leonor S. Oliveira
@da
Maria Leonor S. Oliveira
@de
Maria Leonor S. Oliveira
@en
Maria Leonor S. Oliveira
@es
Maria Leonor S. Oliveira
@eu
Maria Leonor S. Oliveira
@fr
Maria Leonor S. Oliveira
@gl
P106
P1153
7402586601
P21
P31
P496
0000-0003-4849-3062